Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofiâs Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Companyâs products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
äŒæ¥ã³ãŒãSNY
äŒç€ŸåSanofi SA
äžå Žæ¥Jul 01, 2002
æé«çµå¶è²¬ä»»è
ãCEOãHudson (Paul)
åŸæ¥å¡æ°84587
蚌åžçš®é¡Depository Receipt
æ±ºç®ææ«Jul 01
æ¬ç€Ÿæåšå°46 Avenue de la Grande Armee
éœåžPARIS
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœFrance
éµäŸ¿çªå·75017
é»è©±çªå·33153774000
ãŠã§ããµã€ãhttps://www.sanofi.com/
äŒæ¥ã³ãŒãSNY
äžå Žæ¥Jul 01, 2002
æé«çµå¶è²¬ä»»è
ãCEOãHudson (Paul)